To include your compound in the COVID-19 Resource Center, submit it here.

ImmunoGen rises on ADC deal with Jazz

ImmunoGen Inc. (NASDAQ:IMGN) gained $1.12 (17%) to $7.58 on Tuesday after it granted Jazz Pharmaceuticals plc (NASDAQ:JAZZ) an exclusive option to develop and commercialize three of ImmunoGen's antibody-drug

Read the full 289 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE